Compound Kushen injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Compound Kushen injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer

Published:2019-12 Issue:52 Volume:98 Page:e18552
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Chen Hongwei,Yao Xiaojun,Li Ting,Lam Christopher Wai-Kei,Zhang Huixia,Wang Jue,Zhang Wei,Leung Elaine Lai-Han,Wu Qibiao

Funder

the Science and Technology Development Fund, Macau SAR

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference44 articles.

1. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Bray;CA Cancer J Clin,2018

2. Cancer statistics;Siegel;CA Cancer J Clin,2018

3. SphK1 functions downstream of IGF-1 to modulate IGF-1-induced EMT, migration and paclitaxel resistance of A549 cells: A preliminary in vitro study;Wu;J Cancer,2019

4. Epidemiology of lung cancer in China;Cao;Thorac Cancer,2019

5. Annual report on status of cancer in China, 2011;Chen;Chin J Cancer Res,2015

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular insights into gastric cancer: The impact of TGFBR2 and hsa-mir-107 revealed by microarray sequencing and bioinformatics;Computers in Biology and Medicine;2024-04

2. Clinical effect of Danshen decoction in patients with heart failure: A systematic review and meta-analysis of randomized controlled trials;PLOS ONE;2023-05-05

3. Exploring the nucleotide molecular mechanism of compound kushen injection for lung adenocarcinoma based on network pharmacology and molecular docking;Frontiers in Oncology;2022-11-07

4. Clinical efficacy and safety of NSCLC ancillary treatment with compound Kushen injection through immunocompetence regulation: A systematic review and meta-analysis;Phytomedicine;2022-09

5. Compound kushen injection in cancer treatments: Efficacy, active ingredients, and mechanisms;Pharmacological Research - Modern Chinese Medicine;2022-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3